Quantum Genomics wins a great research grant (Boursier.com – french only)
Hypertension: the brain, site of action of the new treatments (Pourquoi Docteur – french only)
Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins (Circulation)
Biopharma companies will be moving into the spotlight (BioWorld – check out page 12)
NEW HOPE: Firibastat lowers BP in high-risk population (Healio)
Quantum Genomics: the first line against high blood pressure and heart failure (Flash Matin / Obs – french only)
HTA: firibastat, leader of a new therapeutic class (Egora.fr – french only)
Patient-Based Culture (PharmaVoice)
Tulane working on new stroke drugs that tweak brain chemistry (The New Orleans Advocate)
Aminopeptidase A inhibitor shows promise for BP lowering in high-risk patients (Healio)